
Keywords: FpA/FpB; fibrinopeptide A/B; PPP; platelet-poor plasma; PTM; posttranslational modification; tPA; tissue plasminogen activator; VTE; venous thromboembolism; MPO; myeloperoxidase; GSH; glutathione; GSNO; S-nitrosoglutathione; Fibrinogen; Fibrin; Coagulatio